Skip to main content Skip to navigation
Commercialization Sustaining Health

The uncompromising pursuit of healthier people and communities

Learn more about Washington State University’s sustaining health research and grand challenges research initiatives. WSU start-ups below focus on innovations ranging from drug candidates to animal diagnostics.

Start-Ups

AAVogen

AAVogen logo
Muscle wasting occurs in patients with cancer, muscular dystrophy, COPD, chronic kidney disease, nerve damage or heart failure. It also occurs with aging and in each situation, can have fatal consequences. AVGN7 is a viral gene therapeutic that blocks the inhibitory actions of myostatin, GDF11 and activin. In animal studies, its specificity for muscle and heart prevents their wasting without the dangerous side effects that have limited competing technologies.

EpigeneSys

EpigeneSys will exploit proprietary technology and initially use contract service providers and collaborators with known clinical cohorts to identify disease associated epigenetic biomarkers and epigenetic signatures.  Subsequently, the Company will develop diagnostic products/services using more appropriate [lower cost] targeted technology and these diagnostics will be provided as a clinical service in a CLIA lab.  The Company is seeking investors and partners to execute the commercialization strategy.

Klar Scientific

Klar specializes in the development of optical instruments for comprehensive materials characterization. Located near Washington State University, we understand the demands of scientific research. Let us know your application.

M3 Biotechnology

M3 Biotechnology is an innovative therapeutics company that has a novel platform of disease-modifying regenerative small molecules, particularly relevant to neurodegenerative diseases. The lead compound modifies growth-factor systems, where the activation is expected to stop disease progression and even restore lost function.

Bioelectrons LLC

Bioelectrons LL is establishing a novel foundation for an alternative to antibiotic-free wound dressings to eliminate infectious species from tissue via the continuous delivery of hydrogen peroxide (H2O2). This highly effective and antibiotic-free scaffold which protects wounds against biofilm invasion without causing oxidative damage could change the way infected wounds are treated.

Chimeric Designs LLC

Chimeric Designs is developing new tools for the detection and treatment of cancer. Their innovative ideas enable rapid development and clinical entry of cancer drugs, with reduced dosage and fewer side effects.

DL ADV-Tech LLC

DL ADV Tech is establishing a novel real-time and rapid system that can be used universally to quantify a wide variety of biomarkers in the fields of medical diagnostics, food safety, public health, and environmental monitoring. With this method, any molecule which can be attached to an antibody can be tested in the field or office without the use of expensive or complicated laboratory equipment.

Kade & Vos

Kade & Vos underwear is designed to fit the curves of your body. Our innovative design approach incorporates fit models with unique, beautiful shapes at every size. So our underwear can truly offer what you need.

Pearl Antigenics

The pursuiting a propitory digonositcs to detect trichomonas vaginalis more accurate and specific and less invasive than existing methods.

Rewire Neuroscience

rewire logo
Rewire Neuroscience is dedicated to empowering the future of neuroscience. Our goal is to help early stage scientists get ahead in a competitive research landscape. We develop products that are well built, affordable, and designed by neuroscientists who use the product.

Service Centers

Veterinary Clinical Pharmacology Lab


Many herding breed dogs have a genetic predisposition to adverse drug reactions involving over a dozen different drugs. The most serious adverse drug reactions involve several antiparasitic agents (ivermectin, milbemycin and related drugs), the antidiarrheal agent loperamide (Imodium), and several anticancer drugs (vincristine, doxorubicin, others). These drug sensitivities result from a mutation in the multidrug resistance gene (MDR1 gene). At Washington State University’s College of Veterinary Medicine you can test your dog for multidrug sensitivity and prevent serious adverse drug reactions. We can work with your dog’s veterinarian to find appropriate drug doses or alternative drugs for your dog based on results of MDR1 testing.

Service Center